home / stock / hepa / hepa articles

HEPA Articles, Hepion Pharmaceuticals Inc.

Stock Information
Company Name: Hepion Pharmaceuticals Inc.
Stock Symbol: HEPA
Market: NYSE
Website: hepionpharma.com
Menu
HEPA HEPA Quote HEPA Short HEPA News HEPA Articles HEPA Message Board
Get HEPA Alerts

News, Short Squeeze, Breakout and More Instantly...
S&P 500 Rises Over 1%; Zions Bancorp Shares Gain After Q1 Earnings | Benzinga

U.S. stocks traded higher toward the end of trading, with the S&P 500 gaining more than 1% on Monday. The Dow traded up 1.02% to 38,373.22 whil...
Why Is Liver-Disease Drug Developer Hepion Pharmaceuticals Stock Trading Lower On Monday? | Benzinga

Friday, Hepion Pharmaceuticals Inc. (NASDAQ:HEPA) said it has begun winding down activities in its ASCEND-NASH Trial while continuing to ...

Why Vaxxinity Shares Are Trading Lower By Around 55%? Here Are Other Stocks Moving In Monday's Mid-Day Session | Benzinga

Shares of Vaxxinity, Inc. (NASDAQ:VAXX) fell sharply during Monday's session after the company announced its intention to voluntarily delist a...

Gold Falls Sharply; Matterport Shares Spike Higher | Benzinga

U.S. stocks traded higher midway through trading, with the Dow Jones gaining around 100 points on Monday. The Dow traded up 0.24% to 38,078.26 whil...
Dow Jumps Over 100 Points; Chicago Fed National Activity Rises In March | Benzinga

U.S. stocks traded higher this morning, with the Dow Jones gaining over 100 points on Monday. Following the market opening Monday, the Dow traded u...

Hepion Pharmaceuticals to Present at the 7th Obesity & NASH Drug Development Summit | Benzinga

EDISON, N.J., Nov. 28, 2023 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company focused o...

Hepion Pharmaceuticals Schedules Conference Call to Review Additional Efficacy Data from Phase 2 'ALTITUDE-NASH' Liver Function Trial of Rencofilstat | Benzinga

EDISON, N.J., Nov. 10, 2023 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company focused o...
Hepion Pharmaceuticals to Participate in 2023 Cantor Global Healthcare Conference | Benzinga

EDISON, N.J., Sept. 21, 2023 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company focused ...

Over $18M Bet On Asana? Check Out These 3 Stocks Insiders Are Buying | Benzinga

Although U.S. stocks closed lower on Wednesday following Fed’s rate decision, there were a few notable insider trades. When insiders purchase...

Hepion Pharmaceuticals Announces Management Changes | Benzinga

EDISON, N.J., Sept. 06, 2023 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company focused ...
Next 10